AKT1 and neoplasm: miR-494 activates the PI3K/Akt pathway by targeting of PTEN and hence not only enhances the ability of myeloid-derived suppressor cells (MDSCs) to infiltrate into tumor tissue but also facilitates tumor invasion and metastasis (50).